drugset
drugset / Trial / NCT04883996

A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia

NCT04883996 ↗

Phase 1/2 Unknown 60 enrolled Canyon City Eyecare Nevakar, Inc. · collab
RandomizedCrossoverTriple-blindTreatment

Summary

Assess the Safety, Pharmacodynamics, and Efficacy of EXP039 Ophthalmic Solution in Participants with Myopia or Hyperopia

Timeline

Start
2020-12-01
Primary completion
2021-07-31
Completion
2021-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator EXP039 Unknown 1 % Other

Indications

hyperopia myopia